Active Ingredient: AMINOSALICYLIC ACID RESIN COMPLEX
Proprietary Name: REZIPAS
Dosage Form; Route of Administration: POWDER; ORAL
Strength: EQ 500MG BASE/GM
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N009052
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BRISTOL MYERS SQUIBB CO
Marketing Status:
Discontinued
Patent and Exclusivity Information